04 September 2008 11:18 [Source: ICIS news]
LONDON (ICIS news)--Bayer CropScience is likely to hit its 25% EBITDA (earnings before interest, tax, depreciation and amortisation) margin target in 2008, a year earlier than planned, and invest around €3.4bn in research and development between 2008 and 2012, the company said on Thursday.
The world’s second largest crop protection products maker said it planned to bring 10 new crop protection active ingredients to market over the period with combined target peak sales of €1bn.
An earlier target to achieve sales of €2bn from active ingredients launched since 2000 was likely to be achieved in 2009, two years earlier than expected, Bayer CropScience said.
The underlying 25% EBITDA margin target was also originally set for 2009.
In the first six months of 2008, the crop protection products leader boosted sales 19%, adjusted for exchange rates and portfolio effects, to €3.78bn. The sales rise was driven by higher volumes and prices.
EBITDA before special items increased by 24% to €1.21bn.
($1 = €0.69)
To discuss issues facing the chemical industry go to ICIS connect
For the latest chemical news, data and analysis that directly impacts your business sign up for a free trial to ICIS news - the breaking online news service for the global chemical industry.
Get the facts and analysis behind the headlines from our market leading weekly magazine: sign up to a free trial to ICIS Chemical Business.
|ICIS news FREE TRIAL|
|Get access to breaking chemical news as it happens.|
|ICIS Global Petrochemical Index (IPEX)|
|ICIS Global Petrochemical Index (IPEX). Download the free tabular data and a chart of the historical index|
Asian Chemical Connections